# OnCo record paper-impower133-n-engl-j-med-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-impower133-n-engl-j-med-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-impower133-n-engl-j-med-2018" ;
  schema:name "First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer"@en ;
  schema:description "Published report from the IMpower133 trial registered as NCT02763579, in New England Journal of Medicine (2018), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-impower133-n-engl-j-med-2018/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa1809064>, <https://pubmed.ncbi.nlm.nih.gov/30280641/>, <https://europepmc.org/article/MED/30280641>, <https://clinicaltrials.gov/study/NCT02763579> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa1809064> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Horn L, Mansfield AS, Szczęsna A, et al." ;
  onco:trials <https://onco.cc/trials/impower133/> ;
  onco:journals <https://onco.cc/journals/nejm/> .